Results 91 to 100 of about 22,304 (253)

Levonorgestrel hormone releasing intrauterine system (Mirena®) as a contraceptive in egg donors: case report [PDF]

, 2005
C. Kailasam, Adebowale Akande, U.D. Gordon   +2 more
openalex   +1 more source

Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.

Cochrane Database of Systematic Reviews, 2017
BACKGROUND In the absence of treatment, endometrial hyperplasia (EH) can progress to endometrial cancer, particularly in the presence of histologic nuclear atypia.
T. Mittermeier, Charlotte Farrant, M. Wise   +2 more
semanticscholar   +1 more source

Emergency contraception today: discussion of experts and practice [PDF]

Гинекология, 2014
Emergency contraception with levonorgestrel for the practicing obstetricians-ginecologist is a well-known method of contraception. The modern science has analyzed the safety issues of its use, and recently has changed the understanding of the method ...
L V Erofeeva, V N Prilepskaya
doaj  

Use of the levonorgestrel-releasing intrauterine system in breast cancer patients [PDF]

, 2007
Xuan Bich Trinh, Wiebren Tjalma, Amin Makar, G. Buytaert, Joost Weyler, Peter A. van Dam   +5 more
openalex   +1 more source

Body‐identical estrogens in combined hormonal contraceptives: A safer path forward

International Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 654-656, January 2026.
Nathalie Chabbert‐Buffet, Ivonne J. Diaz Yamal, Jonathan Douxfils, Jean‐Michel Foidart, Franca Fruzzetti, Kristina Gemzell‐Danielsson, Rossella E. Nappi, Yutaka Osuga, Philippe Descamps   +8 more
wiley   +1 more source

Levonorgestrel-releasing intrauterine system vs. systemic medication or blank control for women with dysmenorrhea: Systematic review and meta-analysis of randomized controlled trials

, 2022
Jing Wang, Ke Deng, Ling Li, Yi Dai, Xin Sun   +4 more
openalex   +1 more source

FDA and EMA Oversight of Disruptive Science on Application of Finite Absorption Time (F.A.T.) Concept in Oral Drug Absorption: Time for Scientific and Regulatory Changes

Pharmaceutics
Background: It has been demonstrated that the concept of infinite absorption time, associated with the absorption rate constant, which drives a drug’s gastrointestinal absorption rate, is not physiologically sound.
Elias Toulitsis, Athanasios A. Tsekouras, Panos Macheras   +2 more
doaj   +1 more source

CONTRACEPCION DE EMERGENCIA: EFECTO POSTFERTILIZACION DEL LEVONORGESTREL

Revista Chilena de Obstetricia y Ginecología, 2003
Para las paciente y médicos que creen que la persona humana comienza su existencia con la fertilización, los métodos de planificación familiar que actúan interrumpiendo el desarrollo embrionario en sus primeras etapas no son éticamente aceptables.
Maritza Busquets C.
doaj  

Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy

, 2020
Rachel S. Mandelbaum, Marcia A. Ciccone, David J. Nusbaum, Mahdi Khoshchehreh, Heena Purswani, Elise Morocco, Meghan B. Smith, Shinya Matsuzaki, Christina E. Dancz, Begüm Özel, Lynda D. Roman, Richard J. Paulson, Koji Matsuo   +12 more
openalex   +2 more sources

Efecto del levonorgestrel como anticonceptivo oral de emergencia en la ovulación, el endometrio y los espermatozoides Effect of levonorgestrel in the ovulation, endometrium, and spermatozoa for emergency oral contraception

Revista Peruana de Medicina Experimental y Salud Pública, 2010
Existe amplia controversia acerca del mecanismo de acción del levonorgestrel como anticonceptivo oral de emergencia; numerosas organizaciones, tanto científicas como de la sociedad civil, muestran su disconformidad con su uso, debido a su posible acción ...
Víctor J. Suárez, Renzo Zavala, Juan Manuel Ureta, Gisely Hijar, Jorge Lucero, Paul Pachas   +5 more
doaj